Therapeutic drug monitoring was helpful in guiding the decision-making process for children receiving infliximab for inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic drug monitoring was helpful in guiding the decision-making process for children receiving infliximab for inflammatory bowel disease

Published:2017-08-24 Issue:11 Volume:106 Page:1863-1867
ISSN:0803-5253
Container-title:Acta Paediatrica
language:en
Short-container-title:Acta Paediatr

Author:

Deora Vini¹,Kozak Justin¹,El-Kalla Mohamed²,Huynh Hien Q.²,El-Matary Wael¹³

Affiliation:

1. Section of Pediatric Gastroenterology; Department of Pediatrics; Max Rady Faculty of Medicine; University of Manitoba; Winnipeg MB Canada

2. Division of Pediatric Gastroenterology; Department of Pediatrics; Faculty of Medicine; University of Alberta; Edmonton AB Canada

3. Department of Pediatrics; University of Alexandria; Alexandria Egypt

Funder

University of Manitoba

Children's Hospital Research Institute of Manitoba

Publisher

Wiley

Subject

General Medicine,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apa.14008/fullpdf

Reference22 articles.

1. Infliximab: use in inflammatory bowel disease;Travassos;Cur Treat Opin Gastroenterol,2005

2. The utility of infliximab therapeutic drug monitoring among patients with inflammatory bowel disease and concerns for loss of response: a retrospective analysis of a real-world experience;Mitchell;Can J Gastroenterol Hepatol,2016

3. Anti - TNF treatment in crohn's disease: towards tailored therapy?;D’ Haens;Am J Gastroenterol,2010

4. Anti - TNF monotherapy for crohn's disease: a 13-year multicentre experience;Peyrin-Biroulet;J Crohns Colitis,2016

5. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial;D'Haens;Lancet,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of proactive therapeutic drug monitoring in guiding infliximab therapeutic optimization in pediatric patients with Crohn's disease: A retrospective study;Pediatric Discovery;2024-06-25

2. Medical management of pediatric inflammatory bowel disease;Seminars in Pediatric Surgery;2024-04

3. Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn’s Disease Exhibit Similar Pharmacokinetics;Inflammatory Bowel Diseases;2024-01-03

4. Retrospective Assessment of an Adalimumab Model–Informed Precision Dosing Support Tool for Use in Pediatric Inflammatory Bowel Disease;The Journal of Pediatric Pharmacology and Therapeutics;2023-11-01

5. Trough Concentration Response in Infliximab and Adalimumab Treated Children With Inflammatory Bowel Disease Following Treatment Adjustment: A Pharmacokinetic Model;Journal of Pediatric Gastroenterology & Nutrition;2023-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3